IRCT201504211556N75已完成3 期
carnosine as adjunctive treatment of negative symptoms in patients with schizophrenia: a double blind and placebo controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •1-Diagnosis of Schizophrenia based on DSM-5 criteria; 2- Age between 18-60; 3-Chronic Schizophrenia- duration of the disorder more than 2 years; 4-Minimum score of 20 in negative sub score. 5-being stable on risperidone for the last 2 months
- •Exclusion criteria:1-Any serious medical or neurological problem; 2- IQ less than 70; 3- Substance dependence during the last 6 months(except for nicotine and caffeine); 4- Score on HDRS less than 14 5-receiving ECT during the last 3 months ; 6-Acute or chronic systemic diseases; 7- History of neurosurgery; 8- History of head trauma.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Carnosine in the treatment of OCDObsessive- Cumpulsive Disorder.Obsessive-compulsive disorderIRCT201604201556N88Tehran University of Medical Sciences50
已完成
3 期
carnosine in SchizophreniaCTRI/2019/02/017646Brio Bliss life science pvtltd100
招募中
2 期
carnosine in treatment of major depressive disorderIRCT20170123032145N2Iran University of Medical Sciences50
已完成
不适用
Effects Of Carnosine On Autismautism disordersAutism Disorder.IRCT2016061711689N4Deputy Of Research And Technology Of Tabriz University Of Medical Science, Nutritional Science Resea50
已完成
不适用
Carnosine in the treatment of AutismAutistic Disorder.Childhood autismIRCT201512081556N83Tehran University of Medical Sciences50